By Iain Gilbert
Date: Thursday 06 Feb 2025
(Sharecast News) - Shares in pharmaceutical giant Bristol Myers Squibb headed south in early trading as its solid Q4 revenue performance was offset by FY25 guidance that fell short of Wall Street expectations.
| Currency | US Dollars |
| Share Price | $ 53.46 |
| Change Today | $ -0.48 |
| % Change | -0.89 % |
| 52 Week High | $63.11 |
| 52 Week Low | $42.60 |
| Volume | 2,794 |
| Shares Issued | 2,006.00m |
| Market Cap | $107,241m |
| Beta | 0.45 |
| RiskGrade | 106 |
| Strong Buy | 5 |
| Buy | 3 |
| Neutral | 18 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 28 |

You are here: research